Novartis | NVS - EPS Earnings Per Share


Novartis reported $1.99 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
2.46 2.28 2.25 Oct/27




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Amgen USD 6.29 1.14 Jun/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Bausch Health Companies USD 1.77 0.51 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Canopy Growth CAD -0.4 0.35 Mar/2026
Corcept Therapeutics USD 0.36 0.66 Jun/2026
Drreddys Laboratories INR 0.06 0.1 Mar/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
J&J USD 2.7 0.2 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Novartis USD 1.99 0.45 Mar/2026
Pacira USD 0.73 0.13 Jun/2026
Perrigo USD 0.5 0.07 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 0.98 0.25 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026
Sanofi EUR 2.17 2.84 Mar/2026
Supernus Pharmaceuticals USD 0.35 1.36 Sep/2026
Zoetis USD 1.87 0.34 Jun/2026